Groundbreaking obesity shot begins human testing
Disease control
Recruiting now
This is the first study in humans testing a new injection called DA-1726 for obesity. Researchers want to see if it's safe and how the body handles it in adults who are otherwise healthy but have obesity. The study will measure side effects and look at early signs of how it might…
Phase: PHASE1 • Sponsor: NeuroBo Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC